ArticleCytotechnology2026
Stable mammalian expression of His-tagged prestin in Chinese hamster ovary cells.
Article in Cytotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chinese hamster ovary (CHO) cells are widely used for the stable production of recombinant proteins, including membrane proteins that require a mammalian cellular environment for proper folding and targeting. Prestin, a motor protein responsible for outer hair cell electromotility in the mammalian cochlea, is a multi-pass membrane protein whose structural and functional analyses require reliable expression systems capable of producing full-length protein. In the present study, we established CHO cell lines stably expressing full-length prestin with a C-terminal 6×histidine (His) tag using mammalian expression vectors driven by either the elongation factor-1α (EF1α) promoter or the cytomegalovirus (CMV) promoter. Following geneticin selection and limiting dilution cloning, multiple clonal cell lines were obtained and characterized by Western blotting, immunofluorescence microscopy and electrophysiological analysis. Seven clones expressing His-tagged prestin were identified. Quantitative Western blot analysis using a calibrated His-tagged reference protein demonstrated that the EF1α-driven system yielded higher-producing clones than the CMV-driven system, with a maximum estimated production of approximately 271 µg per 2 × 10⁹ cells. Immunofluorescence imaging confirmed membrane localization of prestin in expressing clones. Whole-cell patch-clamp recordings revealed nonlinear capacitance, indicating functional activity of the expressed protein. These results demonstrate that CHO cells provide a stable mammalian expression system for the production of full-length His-tagged prestin. The system enables reproducible protein production, quantitative expression evaluation and functional validation within a single cellular background, and may facilitate future biochemical, structural and functional studies of prestin and related membrane proteins. Supplementary Information: The online version contains supplementary material available at 10.1007/s10616-026-00950-8.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.